Home
News
默认头像

Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates

2024-06-07MyfxbookMyfxbook
Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates

(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.

Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Disclaimers

The article is sourced from Myfxbook with the original source credited. The views expressed herein are not affiliated with FXOR; readers are encouraged to approach the content rationally. Copyright belongs to the original author. If unintentional infringement upon media or personal intellectual property rights has occurred, please contact us, and we will promptly remove the content. FXOR merely provides information storage services. The article is compiled and released by FXOR; reprints must indicate the original source.